Effect of Rosiglitazone on Insulin Sensitivity and Body Composition in Type 2 Diabetic Patients
Obesity Research2002Vol. 10(10), pp. 1008–1015
Citations Over TimeTop 10% of 2002 papers
D. Carey, Gary Cowin, Graham J. Galloway, Nigel C. Jones, Jackie C. Richards, Nandita Biswas, David M. Doddrell
Abstract
Our data indicate that RSG greatly improves insulin sensitivity in patients with type 2 diabetes and is associated with an increase in adiposity in subcutaneous but not visceral body regions.
Related Papers
- → Rosiglitazone and Cardiovascular Risk – A Review(2012)
- Rosiglitazone compound formula eliminates the side effects of rosiglitazone(2014)
- The progress of clinical study on rosiglitazone(2003)
- → Re-evaluation of the cardiovascular safety of rosiglitazone(2014)
- → The Effects of Rosiglitazone on in vivo Synthesis of Bone Collagen in Mice(2004)